HCA Holdings (HCA) Elective Procedures Delayed Not Cancelled - Credit Suisse
Tweet Send to a Friend
Credit Suisse analyst A.J. Rice reiterated an Outperform rating and $173.00 price target on HCA Holdings (NYSE: HCA) with shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
